Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-400994
Filing Date
2014-11-06
Accepted
2014-11-06 16:07:10
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d817679d10q.htm 10-Q 304078
2 EX-31.1 d817679dex311.htm EX-31.1 9222
3 EX-31.2 d817679dex312.htm EX-31.2 9574
4 EX-32.1 d817679dex321.htm EX-32.1 5369
  Complete submission text file 0001193125-14-400994.txt   2443447

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT hrtx-20140930.xml EX-101.INS 324998
6 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20140930.xsd EX-101.SCH 23533
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hrtx-20140930_cal.xml EX-101.CAL 17615
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hrtx-20140930_def.xml EX-101.DEF 116798
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20140930_lab.xml EX-101.LAB 168809
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20140930_pre.xml EX-101.PRE 117213
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33221 | Film No.: 141200698
SIC: 2834 Pharmaceutical Preparations